MGRM
Income statement / Annual
Last year (2024), Monogram Orthopaedics, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Monogram Orthopaedics, Inc.'s net income was -$16.33 M.
See Monogram Orthopaedics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00 |
$365,000.00 |
$0.00 |
$628,246.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$430,000.00
|
$0.00
|
$386,686.00
|
$458,675.00
|
$95,694.00
|
$31,763.00
|
$30,957.00
|
$13,354.00
|
| Gross Profit |
$0.00
|
$365,000.00
|
-$386,686.00
|
$169,571.00
|
-$95,694.00
|
-$31,763.00
|
-$30,957.00
|
-$13,354.00
|
| Gross Profit Ratio |
0
|
1
|
0
|
0.27
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$8.79 M
|
$10.59 M
|
$4.97 M
|
$5.28 M
|
$4.67 M
|
$194,287.00
|
$31,700.00
|
$48,317.00
|
| General & Administrative Expenses |
$4.41 M
|
$4.05 M
|
$2.93 M
|
$1.90 M
|
$956,622.00
|
$1.25 M
|
$584,316.00
|
$570,002.00
|
| Selling & Marketing Expenses |
$2.11 M
|
$2.99 M
|
$2.71 M
|
$3.27 M
|
$1.22 M
|
$205,207.00
|
$3,154.00
|
$3,771.00
|
| Selling, General & Administrative Expenses |
$6.52 M
|
$7.05 M
|
$5.64 M
|
$5.17 M
|
$2.18 M
|
$1.45 M
|
$587,470.00
|
$573,773.00
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$15.31 M
|
$17.63 M
|
$10.36 M
|
$10.45 M
|
$6.85 M
|
$1.68 M
|
$650,127.00
|
$635,444.00
|
| Cost And Expenses |
-$15.31 M
|
$17.63 M
|
$10.36 M
|
$10.91 M
|
$6.85 M
|
$1.68 M
|
$650,127.00
|
$635,444.00
|
| Interest Income |
$526,000.00
|
$434,279.00
|
$98,065.00
|
$47,768.00
|
$131,535.00
|
$4,900.00
|
$43.00
|
$61.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$21,661.00
|
$54,250.00
|
$124,470.00
|
$62,184.00
|
$23,612.00
|
| Depreciation & Amortization |
$430,000.00
|
$412,335.00
|
$386,686.00
|
$321,984.00
|
$95,694.00
|
$31,763.00
|
$30,957.00
|
$13,354.00
|
| EBITDA |
-$15.90 M |
-$16.86 M |
-$10.23 M |
-$9.96 M |
-$6.76 M |
-$1.64 M |
-$619,127.00 |
-$622,029.00 |
| EBITDA Ratio |
0
|
-46.18
|
0
|
-15.85
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
-47.31
|
0
|
-16.36
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$1.02 M
|
$3.52 M
|
-$3.08 M
|
-$1.54 M
|
-$2.22 M
|
-$119,570.00
|
-$62,141.00
|
-$36,905.00
|
| Income Before Tax |
-$16.33 M
|
-$13.75 M
|
-$13.69 M
|
-$11.81 M
|
-$9.07 M
|
-$1.80 M
|
-$712,268.00
|
-$658,995.00
|
| Income Before Tax Ratio |
0
|
-37.66
|
0
|
-18.81
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$3.33 M
|
$21,661.00
|
$54,250.00
|
$4,900.00
|
-$30,914.00
|
-$13,293.00
|
| Net Income |
-$16.33 M
|
-$13.75 M
|
-$13.69 M
|
-$11.81 M
|
-$9.07 M
|
-$1.80 M
|
-$712,268.00
|
-$658,995.00
|
| Net Income Ratio |
0
|
-37.66
|
0
|
-18.81
|
0
|
0
|
0
|
0
|
| EPS |
-0.5 |
-0.61 |
-0.47 |
-0.4 |
-0.31 |
-0.0614 |
-0.023 |
-0.0213 |
| EPS Diluted |
-0.5 |
-0.61 |
-0.47 |
-0.4 |
-0.31 |
-0.0614 |
-0.023 |
-0.0213 |
| Weighted Average Shares Out |
$32.57 M
|
$22.41 M
|
$29.25 M
|
$29.25 M
|
$29.25 M
|
$29.25 M
|
$30.92 M
|
$30.92 M
|
| Weighted Average Shares Out Diluted |
$32.57 M
|
$22.41 M
|
$29.25 M
|
$29.25 M
|
$29.25 M
|
$29.25 M
|
$30.92 M
|
$30.92 M
|
| Link |
|
|
|
|
|
|
|
|
